Cognition Therapeutics, Inc. Operating Lease, Expense
Cognition Therapeutics, Inc. (CGTX) reported Operating Lease, Expense of $53.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-07
- Cognition Therapeutics, Inc. operating lease, expense for the quarter ending 2026-06-30 was $53.00K, a 1.85% decline year-over-year.
- Cognition Therapeutics, Inc. operating lease, expense for the quarter ending 2026-03-31 was $47.00K, a 12.96% decline year-over-year.
- Cognition Therapeutics, Inc. operating lease, expense for the quarter ending 2025-12-31 was $54.00K, a 0.00% change year-over-year.
- Cognition Therapeutics, Inc. operating lease, expense for the quarter ending 2025-09-30 was $54.00K, a 1.82% decline year-over-year.
- Cognition Therapeutics, Inc. operating lease, expense for fiscal 2025 was $215.00K, a 1.38% decline from fiscal 2024.
- Cognition Therapeutics, Inc. operating lease, expense for fiscal 2024 was $218.00K, a 1.40% increase from fiscal 2023.
- Cognition Therapeutics, Inc. operating lease, expense for fiscal 2023 was $215.00K, a 5.91% increase from fiscal 2022.
- Cognition Therapeutics, Inc. operating lease, expense for fiscal 2022 was $203.00K, a 24.54% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $53.00K 10-Q · filed 2026-08-07 | $100.00K 10-Q · filed 2026-08-07 | $154.00K derived: sum of 3 quarters · filed 2026-08-07 | $208.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $47.00K 10-Q · filed 2026-05-08 | $101.00K derived: sum of 2 quarters · filed 2026-05-08 | $155.00K derived: sum of 3 quarters · filed 2026-05-08 | $209.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $108.00K derived: sum of 2 quarters · filed 2026-03-26 | $162.00K derived: sum of 3 quarters · filed 2026-08-07 | $215.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $54.00K 10-Q · filed 2025-11-06 | $108.00K derived: sum of 2 quarters · filed 2026-08-07 | $161.00K 10-Q · filed 2025-11-06 | $216.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $54.00K 10-Q · filed 2026-08-07 | $108.00K 10-Q · filed 2026-08-07 | $162.00K derived: sum of 3 quarters · filed 2026-08-07 | $217.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $54.00K 10-Q · filed 2026-05-08 | $108.00K derived: sum of 2 quarters · filed 2026-05-08 | $163.00K derived: sum of 3 quarters · filed 2026-05-08 | $218.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $109.00K derived: sum of 2 quarters · filed 2026-03-26 | $164.00K derived: sum of 3 quarters · filed 2026-03-26 | $218.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $55.00K 10-Q · filed 2025-11-06 | $110.00K derived: sum of 2 quarters · filed 2025-11-06 | $164.00K 10-Q · filed 2025-11-06 | $219.00K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $55.00K 10-Q · filed 2025-08-07 | $109.00K 10-Q · filed 2025-08-07 | $164.00K derived: sum of 3 quarters · filed 2025-08-07 | $217.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $55.00K 10-Q · filed 2025-05-07 | $109.00K derived: sum of 2 quarters · filed 2025-05-07 | $162.00K derived: sum of 3 quarters · filed 2025-05-07 | $216.00K derived: sum of 4 quarters · filed 2025-05-07 | |
| 2023-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $107.00K derived: sum of 2 quarters · filed 2025-03-20 | $161.00K derived: sum of 3 quarters · filed 2025-03-20 | $215.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $53.00K 10-Q · filed 2024-11-13 | $107.00K derived: sum of 2 quarters · filed 2024-11-13 | $161.00K 10-Q · filed 2024-11-13 | $211.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $54.00K 10-Q · filed 2024-08-08 | $108.00K 10-Q · filed 2024-08-08 | $158.00K derived: sum of 3 quarters · filed 2024-08-08 | $208.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $50.00K 10-Q · filed 2024-05-07 | $54.00K 10-Q · filed 2023-05-04 | $104.00K derived: sum of 2 quarters · filed 2024-05-07 | $154.00K derived: sum of 3 quarters · filed 2024-05-07 | $203.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $104.00K derived: sum of 2 quarters · filed 2024-03-26 | $153.00K derived: sum of 3 quarters · filed 2024-03-26 | $203.00K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $50.00K 10-Q · filed 2023-11-02 | $99.00K derived: sum of 2 quarters · filed 2023-11-02 | $149.00K 10-Q · filed 2023-11-02 | $196.00K derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $49.00K 10-Q · filed 2023-08-08 | $99.00K 10-Q · filed 2023-08-08 | $146.00K derived: sum of 3 quarters · filed 2023-08-08 | $180.00K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $50.00K 10-Q · filed 2023-05-04 | $97.00K derived: sum of 2 quarters · filed 2023-05-04 | $131.00K derived: sum of 3 quarters · filed 2023-05-04 | $179.00K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $81.00K derived: sum of 2 quarters · filed 2023-03-23 | $129.00K derived: sum of 3 quarters · filed 2023-03-23 | $163.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $34.00K 10-Q · filed 2022-11-14 | $82.00K derived: sum of 2 quarters · filed 2022-11-14 | $116.00K 10-Q · filed 2022-11-14 | $150.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $48.00K 10-Q · filed 2022-08-09 | $82.00K 10-Q · filed 2022-08-09 | $116.00K derived: sum of 3 quarters · filed 2022-08-09 | $156.00K derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $34.00K 10-Q · filed 2022-05-11 | $68.00K derived: sum of 2 quarters · filed 2022-05-11 | $108.00K derived: sum of 3 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $74.00K derived: sum of 2 quarters · filed 2022-03-30 | $179.00K 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $40.00K 10-Q · filed 2021-11-17 | $145.00K 10-Q · filed 2021-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |